VitaLonga

Clinical trial · Research · 16 Nov 2026

In 323 people having rheumatic valve surgery, a biatrial maze cut recurrent atrial fibrillation more than a left-sided maze

Source: Circulation

What the research found

A multicenter randomized single-blind trial was published online on 16 November 2026, in the 17 November 2026 issue of Circulation. People with persistent or long-standing persistent atrial fibrillation who were having rheumatic mitral valve surgery, with or without another cardiac procedure, were assigned 1 to 1 to a biatrial Cox maze IV or a left-sided maze. All 323 randomized people were analyzed. This was a midlife sample, mean age 56.5 years. 72.1 percent were women. Mean left-atrial diameter was 51.9 mm. The abstract does not give the age spread. At 12 months, freedom from atrial tachyarrhythmias lasting more than 30 seconds, without a rhythm-control treatment, was 78.7 percent (129 of 164) after the biatrial maze and 68.6 percent (109 of 159) after the left-sided maze (adjusted difference 10.7 percent, 1-sided lower 95 percent CI 3 percent, p=0.01). Freedom from a permanent pacemaker was 97.0 percent (159 of 164) and 98.1 percent (156 of 159). That met a noninferiority margin of -5 percent (adjusted difference -1.1 percent, 1-sided lower 95 percent CI -3.9 percent, p for noninferiority 0.01). Surgeons were certified before the trial, and procedures were recorded and reviewed. Registry NCT05021601. A surgical trial, not a guide to choosing an operation. DOI 10.1161/CIRCULATIONAHA.126.083005. Not medical advice.

Evidence level: Clinical trial. This is among the stronger kinds of evidence, but one study rarely settles a question.

Read the original at Circulation

More research news